Advertisement Cmed Group names new CEO of US Organisation - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cmed Group names new CEO of US Organisation

Cmed Group has named Mac McElroy as the new CEO of its US organisation, Cmed Inc.

Most recently, McElroy has worked with Chiltern International for over two years as the executive director of Strategic Development, Americas.

Before joining Chiltern, he served as the vice president of Corporate Development for six years and was a member of the executive management team of CTMS, Inc.

Cmed Global chief executive David Connelly said that Mac brings a breadth of experience, knowledge and skills which will be very valuable not only to Cmed in the US, but the company as a whole.

“He has a great track record of developing strong relationships with clients and partners, and driving quality and growth,” Connelly said.

“The addition of Mac along with our recent appoint of Andrew Kellett as our Group CFO means Cmed now has a particularly strong and impressive senior management team.”